Suchergebnisse - "Gulick, Roy M"

PubPharm (25)

1

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

enthalten in: The New England journal of medicine | 2021

von Landovitz, R. | Donnell, D. | Clement, M. | +107

CommentIn: N Engl J Med. 2021 Aug 12;385(7):652-653. - PMID 34379927

2

Clinical Characteristics of Covid-19 in New York City

enthalten in: The New England journal of medicine | 2020

von Goyal, P. | Choi, J. | Pinheiro, L. | +18

3

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease

enthalten in: PloS one | 2020

von Satlin, M. | Goyal, P. | Magleby, R. | +9

4

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

enthalten in: Nature | 2018

von Mendoza, P. | Gruell, H. | Nogueira, L. | +33

CommentIn: Nature. 2018 Sep;561(7724):468-470. - PMID 30258147

5

Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117

enthalten in: The Journal of experimental medicine | 2018

von Cohen, Y. | Lorenzi, J. | Krassnig, L. | +18

6

No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP) : Findings from HPTN 069/ACTG A5305

enthalten in: PloS one | 2018

von Kapadia, S. | Wu, C. | Mayer, K. | +9

7

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

enthalten in: The Journal of infectious diseases | 2017

von Gulick, R. | Wilkin, T. | Chen, Y. | +26

8

Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery

enthalten in: AIDS (London, England) | 2015

von Cillo, A. | Hilldorfer, B. | Lalama, C. | +10

9

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

enthalten in: Nature | 2015

von Caskey, M. | Klein, F. | Lorenzi, J. | +22

ErratumIn: Nature. 2016 Jul 28;535(7613):580. - PMID 27007847

10

Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1 : a randomized clinical trial in diverse multinational settings

enthalten in: PLoS medicine | 2012

von Campbell, T. | Smeaton, L. | Kumarasamy, N. | +124

CommentIn: PLoS Med. 2012;9(8):e1001291. - PMID 22904690